Jazz Pharmaceuticals Net Worth 2007-2019 | JAZZ

Interactive chart of historical net worth (market cap) for Jazz Pharmaceuticals (JAZZ) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Jazz Pharmaceuticals net worth as of October 22, 2019 is $6.86B.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.855B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.387B 37.19
Takeda Pharmaceutical (TAK) Japan $54.643B 8.55
Astellas Pharma (ALPMY) Japan $31.264B 14.90
Merck (MKGAF) Germany $15.139B 20.66
Eisai (ESALY) Japan $14.704B 22.51
UCB SA (UCBJF) Belgium $14.373B 0.00
Grifols, S.A (GRFS) Spain $14.287B 18.23
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Neurocrine Biosciences (NBIX) United States $8.908B 0.00
IPSEN SA ADR (IPSEY) France $8.872B 0.00
Ionis Pharmaceuticals (IONS) United States $7.764B 16.75
Sage Therapeutics (SAGE) United States $7.279B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Catalent (CTLT) United States $7.112B 28.11
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.094B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Hypermarcas (HYPMY) Brazil $5.279B 18.98
Orion OYJ (ORINY) Finland $5.271B 27.14
United Therapeutics (UTHR) United States $3.685B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.461B 79.35
FibroGen (FGEN) United States $3.411B 85.30
Evotec AG (EVTCY) Germany $3.224B 44.14
Nektar Therapeutics (NKTR) United States $3.108B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.923B 10.48
PTC Therapeutics (PTCT) United States $2.246B 0.00
Tilray (TLRY) Canada $2.191B 0.00
Xencor (XNCR) United States $2.052B 44.75
Portola Pharmaceuticals (PTLA) United States $1.938B 0.00
Zogenix (ZGNX) United States $1.900B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.650B 60.04
Corcept Therapeutics (CORT) United States $1.579B 21.70
USANA Health Sciences (USNA) United States $1.556B 15.60
Heron Therapeutics (HRTX) United States $1.520B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.390B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.261B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.200B 19.80
ArQule (ARQL) United States $1.146B 0.00
Endo (ENDP) Ireland $1.053B 1.85
Theravance Biopharma (TBPH) Cayman Islands $0.975B 0.00
TherapeuticsMD (TXMD) United States $0.917B 0.00
Aerie Pharmaceuticals (AERI) United States $0.900B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.885B 3.95
Spectrum Pharmaceuticals (SPPI) United States $0.883B 0.00
Dova Pharmaceuticals (DOVA) United States $0.816B 0.00
Organogenesis Holdings (ORGO) United States $0.707B 0.00
Karyopharm Therapeutics (KPTI) United States $0.690B 0.00
Concordia (CXRXF) Canada $0.588B 0.00
Flexion Therapeutics (FLXN) United States $0.571B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.561B 0.00
Akebia Therapeutics (AKBA) United States $0.493B 0.00
Indivior (INVVY) United States $0.465B 1.68
Aptorum Group (APM) Hong Kong, SAR China $0.463B 0.00
ChemoCentryx (CCXI) United States $0.463B 0.00
Lannett Co Inc (LCI) United States $0.462B 4.87
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.459B 0.00
Translate Bio (TBIO) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.444B 1.04
ImmunoGen (IMGN) United States $0.402B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Dermira (DERM) United States $0.396B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.389B 0.00
DURECT (DRRX) United States $0.380B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.348B 15.83
Corbus Pharmaceuticals Holdings (CRBP) United States $0.337B 0.00
OptiNose (OPTN) United States $0.321B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Rafael Holdings (RFL) United States $0.312B 0.00
Ardelyx (ARDX) United States $0.308B 0.00
Molecular Templates (MTEM) United States $0.307B 0.00
Recro Pharma (REPH) United States $0.294B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.282B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.265B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.235B 0.00
Xeris Pharmaceuticals (XERS) United States $0.231B 0.00
GlycoMimetics (GLYC) United States $0.221B 0.00
CV Sciences (CVSI) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.204B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.198B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.194B 0.00
CannTrust Holdings (CTST) Canada $0.192B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 30.23
AcelRx Pharmaceuticals (ACRX) United States $0.174B 0.00
Taiwan Liposome (TLC) Taiwan $0.168B 0.00
Ocular Therapeutix (OCUL) United States $0.160B 0.00
Calithera Biosciences (CALA) United States $0.147B 0.00
Concert Pharmaceuticals (CNCE) United States $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
Redhill Biopharma (RDHL) Israel $0.144B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.129B 0.00
MEI Pharma (MEIP) United States $0.126B 0.00
Generex Biotechnology (GNBT) United States $0.126B 0.00
Jounce Therapeutics (JNCE) United States $0.116B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cardiome Pharma (CORV) Canada $0.101B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.085B 32.35
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Aquestive Therapeutics (AQST) United States $0.080B 0.00
MediWound (MDWD) Israel $0.077B 0.00
Lipocine (LPCN) United States $0.076B 0.00
Champions Oncology (CSBR) United States $0.073B 0.00
Majesco Entertainment (PTE) United States $0.073B 0.00
Neos Therapeutics (NEOS) United States $0.072B 0.00
Otonomy (OTIC) United States $0.068B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Natural Alternatives (NAII) United States $0.067B 10.11
Infinity Pharmaceuticals (INFI) United States $0.064B 0.00
AgeX Therapeutics (AGE) United States $0.064B 0.00
Melinta Therapeutics (MLNT) United States $0.063B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
IntelGenx Technologies (IGXT) Canada $0.062B 0.00
Novan (NOVN) United States $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.060B 0.00
Aclaris Therapeutics (ACRS) United States $0.058B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.058B 0.00
ElectroCore (ECOR) United States $0.057B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.051B 0.00
Nivalis Therapeutics (ALPN) United States $0.050B 0.00
Capnia (SLNO) United States $0.046B 0.00
CTI BioPharma (CTIC) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
India Globalization Capital (IGC) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.035B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.032B 0.00
Biomerica (BMRA) United States $0.031B 0.00
PharmAthene (ALT) United States $0.030B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 16.83
Vical (BBI) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Onconova Therapeutics (ONTX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00